China Health Food Readiness: SAMR Blue Hat Registration, Filing and the CBEC Parallel Channel

Since the 2016 dual-track reform, Health Food approval splits in two. Registration (注册) is the heavy path: required for any new functional claim, any ingredient not on the SAMR Filing Catalogue, and any imported product whose function falls outside the Filing scope. Registration involves toxicology, functional testing (animal and/or human), stability, hygiene and a full SAMR technical review — typically 18 to 36 months, with applicants from outside China required to nominate an in-country agent. Filing (备案) is the light path: available only for vitamin/mineral nutrient supplements whose ingredients match the Filing Catalogue raw-material list and whose claims match the Filing-allowed function list. Filing review targets 60 working days. The Blue Hat logo is identical on both — the regulator distinguishes by approval number: 国食健字G (registered, made in China), 国食健字J (registered, imported), 国食健注G/J (registration after 2016), and 国食健备G/J (filing after 2016).

The Health Food Raw Material Catalogue (保健食品原料目录) and the matching Allowed Functional Claims Catalogue (允许保健食品声称的保健功能目录) define the Filing universe. Successive expansions have added vitamins, minerals, coenzyme Q10, melatonin, fish oil EPA/DHA, spirulina, polyextract and a growing list of botanicals with specified raw-material standards. Filing is available only if every ingredient (active and excipient) is on the Raw Material Catalogue at the allowed daily intake, the dosage form is permitted, the function is on the Allowed Claims Catalogue, and the manufacturing site is licensed. An ingredient that misses the Catalogue cuts off the Filing route — the product reverts to the multi-year Registration path or is sold only via CBEC.

Cross-border e-commerce operates under the CBEC Positive List jointly issued by the Ministry of Commerce, General Administration of Customs, SAMR and others (most recently expanded 2024). Products on the list can be sold to Chinese consumers via authorised CBEC platforms (Tmall Global, JD Worldwide, Kaola, Douyin Global, Pinduoduo's Temu-equivalent) and shipped from bonded warehouses or by direct mail, treated for regulatory purposes as personal-use imports. No Blue Hat is required. Per-consumer caps apply: ¥5,000 per single transaction and ¥26,000 per calendar year (as adjusted). The label is the original overseas label, with a Chinese-language insert or platform overlay — not the Blue Hat label. The trade-off: CBEC products cannot be sold through general trade (offline retail, pharmacies, supermarkets) and the channel can be tightened or restricted at policy discretion.

Mandatory national standards (GB standards) drive product quality: GB 16740 (Health Food general standard), GB 2762 (contaminants), GB 2763 (pesticide residues), GB 29921 (pathogens) and product-category-specific GB standards. Manufacturing follows GB 17405 (Health Food GMP) for domestic producers; imported Health Foods need a GMP statement equivalent to GB 17405 from the manufacturing site. Imported Blue Hat products go through CIQ / Customs inspection at every port of entry — sampling for label compliance, microbial limits, contaminant testing and identity. A failed batch is destroyed or re-exported. For CBEC, customs sampling is lighter but still occurs.

Days 1–20: channel choice — Blue Hat Filing, Blue Hat Registration or CBEC-only, with portfolio mapping. Days 21–40: Raw Material Catalogue and Allowed Claims Catalogue gate per SKU. Days 41–80: Filing dossier — composition, stability, hygiene, manufacturer GMP attestation, Chinese-language label and insert. Days 81–110: SAMR Filing submission and clarifications. Days 111–140: in-country agent setup, CIQ pre-shipment testing, bonded warehouse / platform onboarding for any CBEC SKUs. Days 141–170: first shipment, customs clearance, label compliance check. Days 171–180: post-launch surveillance and adverse-event reporting setup (Pharmacovigilance-equivalent reports go through the in-country agent).